Advertisement

Topics

Genmab A/S: Genmab Announces Financial Results for the First Half of 2017

11:04 EDT 9 Aug 2017 | FinanzNachrichten

August 9, 2017; Copenhagen, Denmark;Interim Report for the First Half of 2017Highlights -- USD 554 million in net sales of DARZALEX® (daratumumab); resulting in royalty income of DKK 454 million --...

Original Article: Genmab A/S: Genmab Announces Financial Results for the First Half of 2017

NEXT ARTICLE

More From BioPortfolio on "Genmab A/S: Genmab Announces Financial Results for the First Half of 2017"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...